Royce & Associates LP Lowers Stake in Transcat, Inc. (NASDAQ:TRNS)

Royce & Associates LP lowered its stake in Transcat, Inc. (NASDAQ:TRNS - Free Report) by 7.5% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 473,254 shares of the scientific and technical instruments company's stock after selling 38,447 shares during the period. Royce & Associates LP owned 5.08% of Transcat worth $50,042,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Jones Financial Companies Lllp grew its stake in shares of Transcat by 686.7% in the fourth quarter. Jones Financial Companies Lllp now owns 354 shares of the scientific and technical instruments company's stock worth $37,000 after acquiring an additional 309 shares during the last quarter. Principal Financial Group Inc. grew its position in Transcat by 8.8% during the 3rd quarter. Principal Financial Group Inc. now owns 4,611 shares of the scientific and technical instruments company's stock valued at $557,000 after purchasing an additional 373 shares during the last quarter. Victory Capital Management Inc. grew its position in Transcat by 1.4% during the 4th quarter. Victory Capital Management Inc. now owns 34,710 shares of the scientific and technical instruments company's stock valued at $3,670,000 after purchasing an additional 480 shares during the last quarter. Rhumbline Advisers increased its stake in Transcat by 4.1% during the 4th quarter. Rhumbline Advisers now owns 12,348 shares of the scientific and technical instruments company's stock valued at $1,306,000 after purchasing an additional 486 shares in the last quarter. Finally, Janus Henderson Group PLC raised its holdings in Transcat by 4.5% in the third quarter. Janus Henderson Group PLC now owns 13,941 shares of the scientific and technical instruments company's stock worth $1,684,000 after buying an additional 606 shares during the last quarter. Institutional investors own 98.34% of the company's stock.

Remove Ads

Transcat Stock Performance

TRNS stock traded down $2.08 during trading on Thursday, reaching $69.97. The stock had a trading volume of 54,460 shares, compared to its average volume of 66,469. The stock's 50 day moving average is $84.31 and its two-hundred day moving average is $103.33. The firm has a market cap of $651.35 million, a PE ratio of 37.82 and a beta of 0.66. Transcat, Inc. has a 52 week low of $69.96 and a 52 week high of $147.12. The company has a current ratio of 2.42, a quick ratio of 1.98 and a debt-to-equity ratio of 0.14.

Transcat (NASDAQ:TRNS - Get Free Report) last posted its quarterly earnings data on Monday, January 27th. The scientific and technical instruments company reported $0.45 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.38 by $0.07. Transcat had a net margin of 6.22% and a return on equity of 7.23%. During the same period in the prior year, the business earned $0.56 EPS. As a group, equities analysts anticipate that Transcat, Inc. will post 2.3 earnings per share for the current year.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the stock. HC Wainwright reduced their price target on shares of Transcat from $126.00 to $106.00 and set a "buy" rating for the company in a research report on Wednesday, January 29th. Craig Hallum lifted their target price on Transcat from $113.00 to $125.00 and gave the stock a "buy" rating in a report on Thursday, December 12th. StockNews.com downgraded Transcat from a "hold" rating to a "sell" rating in a report on Wednesday, February 5th. Northland Securities reiterated a "market perform" rating and issued a $85.00 price objective (down from $110.00) on shares of Transcat in a report on Wednesday, January 29th. Finally, Oppenheimer downgraded shares of Transcat from an "outperform" rating to a "market perform" rating in a report on Wednesday, January 29th. One analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average target price of $111.50.

Insider Activity

In related news, Director Craig D. Cairns bought 1,200 shares of the firm's stock in a transaction that occurred on Friday, January 31st. The shares were bought at an average cost of $77.02 per share, with a total value of $92,424.00. Following the acquisition, the director now owns 1,910 shares in the company, valued at $147,108.20. This trade represents a 169.01 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 2.30% of the company's stock.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.